What do Macroeconomics, Creativity and Upfront Payments Have in Common?
What do macroeconomics, creativity and upfront payments have in common? They’re all featured in this week’s issue of BioWorld Insight!
It’s Time for Biopharma to Speak Up
Free speech. Most of us take it for granted. Unless you’re a drug company, that is. Since the FDA doesn’t trust biopharma when it comes to drug promotion, the agency believes that, as the watchdog of public health, it’s justified…
What Micro-Focused Biotechies Can Learn from the Macro Folks
Working in the biotech industry can be a bit like staring into a microscope: you become totally absorbed in the things right in front of your face – your stock price, your clinical progress, your balance sheet – and events…
Extra! Extra! Leukemia Treatment Purposely Misses Holy Grail!
This week’s report of remissions in three advanced leukemia patients after immunotherapy has generated quite a lot of excitement in the media – which, in turn, has led to some backlash amongst the twitterati and in the blogosphere, noting that…
Biopharmas Should Explore Better Ways to Make and Regulate Drugs to Avoid Shortages
What’s causing drug shortages in the U.S., and is it a matter of mechanisms of control or methods of drug production? In 2010, there were shortages of 178 drugs in the U.S., a record-high level. Many drugs on the 2010…
Don’t Price Drugs on What the Market Used to Bear
All those warnings about price pressures and reimbursement woes – they didn’t come from Chicken Little. The sky really could be falling for drugmakers that insist on pricing their products based on what the market used to bear.
The Scariest Thing about Dendreon’s Implosion
As a biotech junkie, I’ll admit I was shocked to the core by Dendreon Corp.’s second-quarter admission that prostate cancer vaccine Provenge (Sipuleucel-T) is thus far not succeeding commercially.
Your Weekly Dose of Science
For every scientific advance I cover, there is another that I look at with regret and ignore. With the increase in overall scientific output, the fact that there is lots of good research that I never get to write about…
Scientists Singin’ on YouTube; Who’s Representin’ for Biotech?
When I was blogging for BNET, one of my favorite posts chronicled the hilarious battle of the bands being waged between laboratory supply companies on YouTube.
Sausage, the Law and Jello
Scientists at Beijing University of Chemical Technology have reported a way to express human-derived gelatin in yeast cells, and suggest that human-derived gelatin might be a useful alternative to pig-and cow derived gelatin for use in the food industry.
Join the Conversation